+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viscosupplementation Market By Type, By Application, By Distribution channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 300 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713015
The global viscosupplementation market was valued at $4,426.4 million in 2021, and is projected to reach $10,914.4 million by 2031, registering a CAGR of 9.5% from 2022 to 2031. Viscosupplementation, is a safe, non-surgical treatment for osteoarthritis. It is Food and Drug Administration (FDA)-approved and more successful for the treatment of patients with early-stage arthritis. During viscosupplementation, a gel-like material (hyaluronic acid) is pushed into the kneecap. The naturally occurring chemical hyaluronic acid is found in the synovial fluid that surrounds joints. It lubricates joints to allow bones to move freely and lessen discomfort. Hyaluronic acid levels in the joints are lower in those with osteoarthritis, which causes pain. The injected gel, which is produced in biological research facilities, functions as a cushion and lubricates the joints. Hyaluronic acid forms protein-protein bonds with a variety of proteins, making ligaments more resilient under strain.

The viscosupplementation market is driven by rise in the prevalence of osteoarthritis, increasing geriatric population and rise in adoption of minimally invasive surgeries. Geriatric population is more susceptible to osteoarthritis, therefore rise in the geriatric population anticipated to fuel the demand of viscosupplementation. Thus, this factor is attributes to drive the growth of viscosupplementation market. For instance, according to the World Health Organization (WHO) in October 2021, by 2030, 1 in 6 population in the world will be aged 60 years or over. In addition, rise in the prevalence of osteoarthritis anticipated to fuel the demand of viscosupplementation, henceforth anticipated to boost the growth of viscosupplementation market. For instance, according to Centers for Disease Control, (CDC), it was reported that, by 2040, an estimated 78 million (26%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis. In addition, rise in the demand for minimally invasive viscosupplementation procedures for treatment of osteoarthritis will enhance the industry growth. The minimally invasive treatment replaces synovial fluid by intra-articular injection of hyaluronic acid. As the cost of minimally invasive procedures is significantly less than the conventional procedures, the market will witness considerable growth during the forecast period.

In addition, governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2019 to 2020 reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment, medicine and material used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for viscosupplementation application in osteoarthritis treatment, thereby boosting the market growth.

On the other hand, high cost of hyaluronic acid and presence of alternative for knee osteoarthritis treatment are some factors that are anticipated to restrain the growth of the viscosupplementation market.

The viscosupplementation market is segmented on the basis of product, application, distribution channel, and region. On the basis of product, the market is segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. On the basis of application, the market is bifurcated into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and others. On the basis of knee osteoarthritis market is divided into gender. On the basis of distribution channel, the market is classified into hospital pharmacies, retail pharmacies and online pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global viscosupplementation market include Seikagaku Corporation, Anika Therapeutics, Inc. APTISSEN, Avanos Medical, Inc., Bioventus, Chugai Pharmaceutical Corp., Fidia Farmaceutici S.P.A, Laboratoires VIVACY, LG Life Sciences Ltd., Miravo Healthcare, Neopharmed Gentili S.p.A., Sanofi, SingHealth Group., Smith & Nephew PLC, Viatris, Zimmer Biomet.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the viscosupplementation market analysis from 2021 to 2031 to identify the prevailing viscosupplementation market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the viscosupplementation market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global viscosupplementation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

By Application

  • Others
  • Knee Osteoarthritis
  • Gender
  • Male
  • Female
  • Hip Osteoarthritis
  • Hand Osteoarthritis

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest Of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA

Key Market Players

  • Seikagaku Corporation
  • Anika Therapeutics, Inc.
  • aptissen
  • Avanos Medical, Inc.
  • Bioventus
  • Chugai Pharmaceutical Corp.
  • Fidia Farmaceutici S.P.A
  • LG Life Sciences Ltd.
  • Sanofi
  • Miravo Healthcare
Frequently Asked Questions about the Global Viscosupplementation Market

What is the estimated value of the Global Viscosupplementation Market?

The Global Viscosupplementation Market was estimated to be valued at $4426.4 million in 2021.

What is the growth rate of the Global Viscosupplementation Market?

The growth rate of the Global Viscosupplementation Market is 9.4%, with an estimated value of $10914.4 million by 2031.

What is the forecasted size of the Global Viscosupplementation Market?

The Global Viscosupplementation Market is estimated to be worth $10914.4 million by 2031.

Who are the key companies in the Global Viscosupplementation Market?

Key companies in the Global Viscosupplementation Market include Seikagaku Corporation, Anika Therapeutics, Inc., aptissen, Avanos Medical, Inc., Bioventus, Chugai Pharmaceutical Corp., Fidia Farmaceutici S.P.A, LG Life Sciences Ltd. and Miravo Healthcare.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: VISCOSUPPLEMENTATION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Single Injection Viscosupplementation
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Three Injection Viscosupplementation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Five Injection Viscosupplementation
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country

CHAPTER 5: VISCOSUPPLEMENTATION MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Knee Osteoarthritis
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Knee Osteoarthritis Viscosupplementation Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Hip Osteoarthritis
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Hand Osteoarthritis
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country

CHAPTER 6: VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Retail Pharmacies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Online Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: VISCOSUPPLEMENTATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America Knee Osteoarthritis Viscosupplementation Market by Gender
7.2.4 North America Market size and forecast, by Distribution channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Distribution channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Distribution channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Distribution channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe Knee Osteoarthritis Viscosupplementation Market by Gender
7.3.4 Europe Market size and forecast, by Distribution channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Distribution channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Distribution channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Distribution channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Distribution channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by Distribution channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by Distribution channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific Knee Osteoarthritis Viscosupplementation Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by Distribution channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Distribution channel
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Distribution channel
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Distribution channel
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Distribution channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Distribution channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by Distribution channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA Knee Osteoarthritis Viscosupplementation Market by Gender
7.5.4 LAMEA Market size and forecast, by Distribution channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Distribution channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Distribution channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Distribution channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Distribution channel

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Seikagaku Corporation
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Anika Therapeutics, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 aptissen
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Avanos Medical, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bioventus
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Chugai Pharmaceutical Corp.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Fidia Farmaceutici S. P. A
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 LG Life Sciences Ltd.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sanofi
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Miravo Healthcare
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

List of Tables
Table 1. Global Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 2. Viscosupplementation Market, for Single Injection Viscosupplementation, by Region, 2021-2031 ($Million)
Table 3. Viscosupplementation Market for Single Injection Viscosupplementation, by Country, 2021-2031 ($Million)
Table 4. Viscosupplementation Market, for Three Injection Viscosupplementation, by Region, 2021-2031 ($Million)
Table 5. Viscosupplementation Market for Three Injection Viscosupplementation, by Country, 2021-2031 ($Million)
Table 6. Viscosupplementation Market, for Five Injection Viscosupplementation, by Region, 2021-2031 ($Million)
Table 7. Viscosupplementation Market for Five Injection Viscosupplementation, by Country, 2021-2031 ($Million)
Table 8. Global Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 9. Viscosupplementation Market, for Knee Osteoarthritis, by Region, 2021-2031 ($Million)
Table 10. Viscosupplementation Market for Knee Osteoarthritis, by Country, 2021-2031 ($Million)
Table 11. Global Knee Osteoarthritis Viscosupplementation Market, by Gender, 2021-2031 ($Million)
Table 12. Viscosupplementation Market, for Male, by Region, 2021-2031 ($Million)
Table 13. Viscosupplementation Market, for Female, by Region, 2021-2031 ($Million)
Table 14. Viscosupplementation Market, for Hip Osteoarthritis, by Region, 2021-2031 ($Million)
Table 15. Viscosupplementation Market for Hip Osteoarthritis, by Country, 2021-2031 ($Million)
Table 16. Viscosupplementation Market, for Hand Osteoarthritis, by Region, 2021-2031 ($Million)
Table 17. Viscosupplementation Market for Hand Osteoarthritis, by Country, 2021-2031 ($Million)
Table 18. Viscosupplementation Market, for Others, by Region, 2021-2031 ($Million)
Table 19. Viscosupplementation Market for Others, by Country, 2021-2031 ($Million)
Table 20. Global Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 21. Viscosupplementation Market, for Hospital Pharmacies, by Region, 2021-2031 ($Million)
Table 22. Viscosupplementation Market for Hospital Pharmacies, by Country, 2021-2031 ($Million)
Table 23. Viscosupplementation Market, for Retail Pharmacies, by Region, 2021-2031 ($Million)
Table 24. Viscosupplementation Market for Retail Pharmacies, by Country, 2021-2031 ($Million)
Table 25. Viscosupplementation Market, for Online Pharmacies, by Region, 2021-2031 ($Million)
Table 26. Viscosupplementation Market for Online Pharmacies, by Country, 2021-2031 ($Million)
Table 27. Viscosupplementation Market, by Region, 2021-2031 ($Million)
Table 28. North America Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 29. North America Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 30. North America Knee Osteoarthritis Viscosupplementation Market, by Gender, 2021-2031 ($Million)
Table 31. North America Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 32. North America Viscosupplementation Market, by Country, 2021-2031 ($Million)
Table 33. U.S. Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 34. U.S. Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 35. U.S. Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 36. Canada Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 37. Canada Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 38. Canada Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 39. Mexico Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 40. Mexico Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 41. Mexico Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 42. Europe Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 43. Europe Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 44. Europe Knee Osteoarthritis Viscosupplementation Market, by Gender, 2021-2031 ($Million)
Table 45. Europe Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 46. Europe Viscosupplementation Market, by Country, 2021-2031 ($Million)
Table 47. Germany Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 48. Germany Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 49. Germany Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 50. France Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 51. France Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 52. France Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 53. UK Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 54. UK Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 55. UK Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 56. Italy Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 57. Italy Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 58. Italy Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 59. Spain Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 60. Spain Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 61. Spain Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 62. Rest of Europe Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 63. Rest of Europe Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 64. Rest of Europe Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 65. Asia-Pacific Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 66. Asia-Pacific Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 67. Asia-Pacific Knee Osteoarthritis Viscosupplementation Market, by Gender, 2021-2031 ($Million)
Table 68. Asia-Pacific Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 69. Asia-Pacific Viscosupplementation Market, by Country, 2021-2031 ($Million)
Table 70. China Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 71. China Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 72. China Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 73. Japan Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 74. Japan Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 75. Japan Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 76. India Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 77. India Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 78. India Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 79. Australia Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 80. Australia Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 81. Australia Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 82. South Korea Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 83. South Korea Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 84. South Korea Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 85. Rest of Asia-Pacific Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 86. Rest of Asia-Pacific Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 87. Rest of Asia-Pacific Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 88. LAMEA Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 89. LAMEA Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 90. LAMEA Knee Osteoarthritis Viscosupplementation Market, by Gender, 2021-2031 ($Million)
Table 91. LAMEA Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 92. LAMEA Viscosupplementation Market, by Country, 2021-2031 ($Million)
Table 93. Brazil Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 94. Brazil Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 95. Brazil Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 96. Saudi Arabia Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 97. Saudi Arabia Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 98. Saudi Arabia Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 99. South Africa Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 100. South Africa Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 101. South Africa Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 102. Rest of LAMEA Viscosupplementation Market, by Type, 2021-2031 ($Million)
Table 103. Rest of LAMEA Viscosupplementation Market, by Application, 2021-2031 ($Million)
Table 104. Rest of LAMEA Viscosupplementation Market, by Distribution Channel, 2021-2031 ($Million)
Table 105. Seikagaku Corporation: Company Snapshot
Table 106. Seikagaku Corporation: Operating Segments
Table 107. Seikagaku Corporation: Product Portfolio
Table 108. Seikagaku Corporation: Net Sales
Table 109. Seikagaku Corporation: Key Strategies
Table 110. Anika Therapeutics, Inc.: Company Snapshot
Table 111. Anika Therapeutics, Inc.: Operating Segments
Table 112. Anika Therapeutics, Inc.: Product Portfolio
Table 113. Anika Therapeutics, Inc.: Net Sales
Table 114. Anika Therapeutics, Inc.: Key Strategies
Table 115. Aptissen: Company Snapshot
Table 116. Aptissen: Operating Segments
Table 117. Aptissen: Product Portfolio
Table 118. Aptissen: Net Sales
Table 119. Aptissen: Key Strategies
Table 120. Avanos Medical, Inc.: Company Snapshot
Table 121. Avanos Medical, Inc.: Operating Segments
Table 122. Avanos Medical, Inc.: Product Portfolio
Table 123. Avanos Medical, Inc.: Net Sales
Table 124. Avanos Medical, Inc.: Key Strategies
Table 125. Bioventus: Company Snapshot
Table 126. Bioventus: Operating Segments
Table 127. Bioventus: Product Portfolio
Table 128. Bioventus: Net Sales
Table 129. Bioventus: Key Strategies
Table 130. Chugai Pharmaceutical Corp.: Company Snapshot
Table 131. Chugai Pharmaceutical Corp.: Operating Segments
Table 132. Chugai Pharmaceutical Corp.: Product Portfolio
Table 133. Chugai Pharmaceutical Corp.: Net Sales
Table 134. Chugai Pharmaceutical Corp.: Key Strategies
Table 135. Fidia Farmaceutici S. P. A: Company Snapshot
Table 136. Fidia Farmaceutici S. P. A: Operating Segments
Table 137. Fidia Farmaceutici S. P. A: Product Portfolio
Table 138. Fidia Farmaceutici S. P. A: Net Sales
Table 139. Fidia Farmaceutici S. P. A: Key Strategies
Table 140. Lg Life Sciences Ltd.: Company Snapshot
Table 141. Lg Life Sciences Ltd.: Operating Segments
Table 142. Lg Life Sciences Ltd.: Product Portfolio
Table 143. Lg Life Sciences Ltd.: Net Sales
Table 144. Lg Life Sciences Ltd.: Key Strategies
Table 145. Sanofi: Company Snapshot
Table 146. Sanofi: Operating Segments
Table 147. Sanofi: Product Portfolio
Table 148. Sanofi: Net Sales
Table 149. Sanofi: Key Strategies
Table 150. Miravo Healthcare: Company Snapshot
Table 151. Miravo Healthcare: Operating Segments
Table 152. Miravo Healthcare: Product Portfolio
Table 153. Miravo Healthcare: Net Sales
Table 154. Miravo Healthcare: Key Strategies

List of Figures
Figure 1. Viscosupplementation Market Segmentation
Figure 2. Viscosupplementation Market, 2021-2031
Figure 3. Viscosupplementation Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Viscosupplementation Mark.:Drivers, Restraints and Opportunities
Figure 12. Viscosupplementation Market, By Type, 2021(%)
Figure 13. Comparative Share Analysis of Single Injection Viscosupplementation Viscosupplementation Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Three Injection Viscosupplementation Viscosupplementation Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Five Injection Viscosupplementation Viscosupplementation Market, 2021-2031(%)
Figure 16. Viscosupplementation Market, By Application, 2021(%)
Figure 17. Comparative Share Analysis of Knee Osteoarthritis Viscosupplementation Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Hip Osteoarthritis Viscosupplementation Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Hand Osteoarthritis Viscosupplementation Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of Others Viscosupplementation Market, 2021-2031(%)
Figure 21. Viscosupplementation Market, By Distribution Channel, 2021(%)
Figure 22. Comparative Share Analysis of Hospital Pharmacies Viscosupplementation Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Retail Pharmacies Viscosupplementation Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Online Pharmacies Viscosupplementation Market, 2021-2031(%)
Figure 25. Viscosupplementation Market by Region, 2021
Figure 26. U.S. Viscosupplementation Market, 2021-2031($Million)
Figure 27. Canada Viscosupplementation Market, 2021-2031($Million)
Figure 28. Mexico Viscosupplementation Market, 2021-2031($Million)
Figure 29. Germany Viscosupplementation Market, 2021-2031($Million)
Figure 30. France Viscosupplementation Market, 2021-2031($Million)
Figure 31. Uk Viscosupplementation Market, 2021-2031($Million)
Figure 32. Italy Viscosupplementation Market, 2021-2031($Million)
Figure 33. Spain Viscosupplementation Market, 2021-2031($Million)
Figure 34. Rest of Europe Viscosupplementation Market, 2021-2031($Million)
Figure 35. China Viscosupplementation Market, 2021-2031($Million)
Figure 36. Japan Viscosupplementation Market, 2021-2031($Million)
Figure 37. India Viscosupplementation Market, 2021-2031($Million)
Figure 38. Australia Viscosupplementation Market, 2021-2031($Million)
Figure 39. South Korea Viscosupplementation Market, 2021-2031($Million)
Figure 40. Rest of Asia-Pacific Viscosupplementation Market, 2021-2031($Million)
Figure 41. Brazil Viscosupplementation Market, 2021-2031($Million)
Figure 42. Saudi Arabia Viscosupplementation Market, 2021-2031($Million)
Figure 43. South Africa Viscosupplementation Market, 2021-2031($Million)
Figure 44. Rest of LAMEA Viscosupplementation Market, 2021-2031($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap of Top 10 Key Players
Figure 51. Seikagaku Corporatio.: Net Sales, ($Million)
Figure 52. Anika Therapeutics, Inc.: Net Sales, ($Million)
Figure 53. Aptisse.: Net Sales, ($Million)
Figure 54. Avanos Medical, Inc.: Net Sales, ($Million)
Figure 55. Bioventu.: Net Sales, ($Million)
Figure 56. Chugai Pharmaceutical Corp.: Net Sales, ($Million)
Figure 57. Fidia Farmaceutici S.P..: Net Sales, ($Million)
Figure 58. Lg Life Sciences Ltd.: Net Sales, ($Million)
Figure 59. Sanof.: Net Sales, ($Million)
Figure 60. Miravo Healthcar.: Net Sales, ($Million)

Executive Summary

According to the report, “Viscosupplementation Market," the viscosupplementation market size was valued at $4.4 billion in 2021, and is estimated to reach $10.9 billion by 2031, growing at a CAGR of 9.5% from 2022 to 2031. Viscosupplementation is a minimally invasive treatment option for osteoarthritis patients. In a treatment called viscosupplementation, hyaluronic acid is injected into the patient's knee joint. The fluids of the joints and eyes contain large concentrations of hyaluronic acid, a naturally occurring lubricant. This fluid is crucial in lowering inflammation and pain in arthritic joints like the knee.

Factors that drive growth of the viscosupplementation market size include rise in number of product launch for viscosupplementation, increase in geriatric population and rise in prevalence of osteoarthritis. In addition, rise in adoption of minimally invasive surgeries and increase on adoption of key strategies such as acquisition, collaboration, partnership and agreement by viscosupplementation industry anticipated to fuel viscosupplementation market analysis. For instance, in Feb 2020, Anika Therapeutics. Inc. a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic Acid (HA) technology platform, announced the complete acquisition of Arthrosurface, a leading, privately-held provider of joint surface and preservation solutions for active patients. This acquisition significantly enhances Anika’s commercial capabilities in the U.S. and accelerates its product platform strategy by further expanding portfolio and pipeline across the joint preservation and restoration continuum. Moreover, technological advancement to treat osteoarthritis and increase in number of product launch anticipated to drive the growth of market. For instance, in March 2019, Seikagaku Corporation, a pharmaceutical company announced the launch of HyLink, an Intra-Articular Single-Injection viscosupplement for the Treatment of Knee Osteoarthritis in Italy.

In addition, geriatric population is more susceptible to orthopedic diseases like osteoarthritis. Rise in the prevalence of osteoarthritis cause increase in the demand of viscosupplementation, and surge the viscosupplementation market trends. Thus, this factor is anticipated to fuel the growth of viscosupplementation market. For instance, in 2020, according to the Journal of eClinicalMedicine around 654⋅1 million individuals (40 years and older) were diagnosed with knee osteoarthritis, across the globe. Furthermore, in September 2021, the American Academy of Orthopedic Surgeons (AAOS) released updates, clinical practice guideline indicating the high molecular weight cross linked hyaluronic treatments for knee osteoarthritis.

On the basis of type, the market is segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. The single injection viscosupplementation segment dominated the market in 2021, and is expected to continue this trend during the viscosupplementation market forecast period, owing to rise in the number of product launch for single injection viscosupplementation and reduction of injection volume makes administration of single injection viscosupplementation easier for healthcare professionals and more comfortable for patients.

On the basis of application, the market is bifurcated into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and others. The knee osteoarthritis segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in the prevalence of knee osteoarthritis and rising geriatric population who is more susceptible to knee osteoarthritis.

On the basis of distribution channel, the market is classified into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacies segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in number of hospitals and rise in expenditure by government to develop healthcare infrastructure.

North America accounted for a majority of the global viscosupplementation market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in product launch and product approval of viscosupplementation and high presence of viscosupplementation industry who manufactures viscosupplementation product. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in expenditure by government organization to develop healthcare sector, increase in geriatric population.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global viscosupplementation market. The COVID-19 pandemic has stressed healthcare systems of the world. A huge number of clinics, hospitals across the globe, were restructured to increase the hospital capacity for the patient diagnosed with COVID-19. Most of the non-emergency and minor procedures got cancel or postpone during pandemic. The demand for viscosupplementation decreased, owing to flight cancellations; travel bans & quarantines; restriction of all indoor/outdoor events; emergency declaration; and massive slowing of supply chain of raw material. Thus, the outbreak of COVID-19 has negatively impacted the viscosupplementation market.

Key Findings of the Study

  • By type, the single injection viscosupplementation segment was the highest contributor to the market in 2021.
  • By application, the knee osteoarthritis segment was the highest contributor to the market in 2021.
  • By distribution channel, the hospital pharmacies segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Seikagaku Corporation
  • Anika Therapeutics, Inc.
  • aptissen
  • Avanos Medical, Inc.
  • Bioventus
  • Chugai Pharmaceutical Corp.
  • Fidia Farmaceutici S.P.A
  • LG Life Sciences Ltd.
  • Sanofi
  • Miravo Healthcare

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...